Ligand Pharmaceuticals LGND reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Ligand Pharmaceuticals reported an EPS of $1.03.
Revenue was down $27.26 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 5.54% drop in the share price the next day.
Here's a look at Ligand Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 0.66 | 1.37 | 1.04 | 1.34 |
EPS Actual | 0.76 | 1.80 | 1.58 | 1.63 |
Revenue Estimate | 34.21M | 65.32M | 55.65M | 70.41M |
Revenue Actual | 45.69M | 72.47M | 64.83M | 84.67M |
To track all earnings releases for Ligand Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.